Publications
108 publications
Funding
5 grantsView NIH portfolio on RePORTER ↗
Active
3 grants- MPIProject 2: Overcoming Microenvironment-Mediated Resistance to AR Pathway Inhibition in High-Risk Prostate CancerNCI · 2001–2027 · via NIH RePORTERP50CA092629-25
- MPIPSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapyNCI · 2021–2027 · via NIH RePORTERR01CA257811-05
Completed grants (2)
- MPIProject 3: Defining the appropriate context for targeting kinase signaling in combination with androgen receptor blockade to enhance therapeutic response in metastatic prostate cancerNCI · 2017–2023 · via NIH RePORTERU54CA224079-04
- PIDefining Response and Resistance to PI3K and AR inhibition in Prostate CancerNCI · 2014–2020 · via NIH RePORTERR01CA182503-05